CompletedNCT05023759
Anxiety symptoms and use of full-spectrum hemp-derived cannabidiol
About this title
Read the official source — NCT05023759Observational studyAges 21–85United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 85 years.
- Listed locations
- Denton and 5 more locationsSee all locations and recruitment
Study information
Study start dateStarted: June 1, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Formula30A LLC
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 21 Years to 85 Years
- Official registry ID
- NCT05023759
- Official title
Show the full official title
Anxiety Symptoms in Relation to Use of Hemp-Derived, Full Spectrum Cannabidiol (CBD): a Cohort Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Denton, United States · Edinburg, United States · Forney, United States
2 more locations
- Southlake, United States
- Ceiba, Puerto Rico
Questions about this study
Who is behind this study?
The study sponsor is Formula30A LLC.
Who was this study for?
Listed age limits: 21 years to 85 years.
